-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2022.
- Tg Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $68K, a 10.5% decline year-over-year.
- Tg Therapeutics, Inc. annual Depreciation for 2022 was $303K, a 7.45% increase from 2021.
- Tg Therapeutics, Inc. annual Depreciation for 2021 was $282K, a 78.5% increase from 2020.
- Tg Therapeutics, Inc. annual Depreciation for 2020 was $158K, a 58% increase from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)